drugset / Trial / NCT02125162

A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

NCT02125162 ↗

Phase 1 Completed 28 enrolled BioCryst Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare how the body takes up and then eliminates the study drug BCX4161 when it is taken orally as a hard gelatin capsule and as a soft gelatin capsule. This study will also evaluate whether food has any effect on how the body takes up BCX4161.

Timeline

Start
2014-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject avoralstat Small molecule 400 mg Oral

Indications